Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Zoetis Inc.

Market Cap 34.13B 29.47B 27.16B 25.42B 47.64B 3,244B 48.38B 321B 125B 1,579B 128B 125B 5,467B P/E Ratio 2026 *
12.6x
P/E Ratio 2027 * 11.6x
Enterprise Value 40.86B 35.29B 32.52B 30.44B 57.05B 3,884B 57.93B 384B 150B 1,890B 153B 150B 6,546B EV / Sales 2026 *
4.18x
EV / Sales 2027 * 3.92x
Free-Float
83.58%
Yield 2026 *
2.66%
Yield 2027 * 2.84%
1 day-1.54%
1 week+0.06%
Current month+2.42%
1 month+3.78%
3 months-33.58%
6 months-32.37%
Current year-36.76%
1 week 77.7
Extreme 77.7
82.98
1 month 72.38
Extreme 72.38
82.98
Current year 72.38
Extreme 72.38
132.49
1 year 72.38
Extreme 72.38
167.38
3 years 72.38
Extreme 72.38
201.92
5 years 72.38
Extreme 72.38
249.27
10 years 45.28
Extreme 45.28
249.27
Manager TitleAgeSince
Chief Executive Officer 54 01/01/2020
Director of Finance/CFO 54 01/06/2021
Chief Tech/Sci/R&D Officer 49 01/01/2026
Director TitleAgeSince
Director/Board Member 68 01/07/2012
Director/Board Member 68 01/01/2013
Chairman 73 26/06/2013
Date Insider Type Main position Quantity % Market Cap.
05-21Fiscal year

Director

3,144 0.0007%
05-20Fiscal year

Director

24,261 0.0058%
05-13Buy

Director

2,000 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-2.25%+0.06%-52.16%-51.21% 34.13B
+0.50%-2.19%+69.38%+166.78% 12.01B
+1.20%-3.15%+5.18%+30.42% 4.56B
+1.61%-0.85%+8.92%+20.42% 3.31B
+2.93%+7.72%+62.86%+22.80% 1.92B
+0.67%+6.38%-30.78%+2.04% 1.65B
+0.86%-2.78%+28.64%+129.64% 1.27B
+4.84%-0.06%-25.98%-8.61% 1.01B
+1.96%+2.58%-4.26%-43.47% 998M
-0.29%+1.01%-5.03%-21.64% 939M
Average +1.28%+0.79%+5.68%+24.72% 6.18B
Weighted average by Cap. -0.34%+0.90%-13.31%+9.73%

Financials

2026 *2027 *
Net sales 9.78B 8.44B 7.78B 7.28B 13.65B 929B 13.86B 91.88B 35.82B 452B 36.69B 35.91B 1,566B 10.18B 8.79B 8.1B 7.59B 14.22B 968B 14.44B 95.69B 37.31B 471B 38.21B 37.4B 1,631B
Net income 2.69B 2.33B 2.14B 2.01B 3.76B 256B 3.82B 25.32B 9.87B 125B 10.11B 9.9B 432B 2.92B 2.53B 2.33B 2.18B 4.08B 278B 4.15B 27.48B 10.72B 135B 10.98B 10.74B 468B
Net Debt 6.74B 5.82B 5.36B 5.02B 9.4B 640B 9.55B 63.3B 24.68B 312B 25.28B 24.74B 1,079B 5.82B 5.03B 4.63B 4.34B 8.13B 553B 8.25B 54.7B 21.33B 269B 21.85B 21.38B 932B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
13/06/26 79.57 $ -2.25% 6,557,534
11/06/26 81.40 $ +0.14% 7,261,950
10/06/26 81.29 $ -1.11% 7,064,438
09/06/26 82.20 $ +4.29% 6,991,570
08/06/26 78.82 $ -0.78% 5,432,076
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
81.40USD
Average target price
124.59USD
Spread / Average Target
+53.06%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!